Circular Genomics and Vitazi.ai Forge Strategic Alliance to Develop First-in-Class Multimodal Workflow for Early Alzheimer's Detection

Circular Genomics, the precision neurology leader pioneering circular RNA (circRNA)-based molecular diagnostics, today announced a strategic alliance with Vitazi.ai, an innovator in AI-powered retinal imaging and oculomics, to jointly develop a next-generation multimodal workflow for the early detection and risk stratification of Alzheimer's disease (AD).